eflornithine has been researched along with Diabetic Glomerulosclerosis in 3 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miracle, CM | 1 |
| Rieg, T | 1 |
| Mansoury, H | 1 |
| Vallon, V | 2 |
| Thomson, SC | 2 |
| Hostetter, TH | 1 |
| Deng, A | 1 |
| Bao, D | 1 |
| Satriano, J | 1 |
| Blantz, RC | 1 |
3 other studies available for eflornithine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Ornithine decarboxylase inhibitor eliminates hyperresponsiveness of the early diabetic proximal tubule to dietary salt.
Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Efl | 2008 |
Hypertrophy and hyperfunction of the diabetic kidney.
Topics: Animals; Diabetic Nephropathies; Eflornithine; Enzyme Inhibitors; Glomerular Filtration Rate; Humans | 2001 |
Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes.
Topics: Animals; Carboxy-Lyases; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Eflornithine; Enzy | 2001 |